PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Journal of the American College of Cardiology122 citationsOpen Access

Translational Perspective on Epigenetics in Cardiovascular Disease

View Full Paper
PHPim van der HarstLWLeón J. De WindtJCJohn C. Chambers

Key Points

  • The research aims to explore the role of epigenetic modifications in cardiovascular disease development and potential therapeutic approaches.
  • Comprehensive review of existing literature on epigenetics and cardiovascular disease.
  • Evaluation of molecular pathways and biomarkers associated with disease progression.
  • Discussion of potential interventions targeting epigenetic mechanisms.
  • Identified critical epigenetic modifications significantly associated with cardiovascular disease.
  • Found potential biomarkers for early detection and risk assessment of cardiovascular conditions.
  • Highlighted promising therapeutic strategies that leverage epigenetic approaches.

Abstract

A plethora of environmental and behavioral factors interact, resulting in changes in gene expression and providing a basis for the development and progression of cardiovascular diseases. Heterogeneity in gene expression responses among cells and individuals involves epigenetic mechanisms. Advancing technology allowing genome-scale interrogation of epigenetic marks provides a rapidly-expanding view of the complexity and diversity of the epigenome. In this review, we discuss the expanding landscape of epigenetic modifications and highlight their importance for our future understanding of disease. The epigenome provides a mechanistic link between environmental exposures and gene expression profiles ultimately leading to disease. We discuss the current evidence for transgenerational epigenetic inheritance and summarize the data linking epigenetics to cardiovascular disease. Furthermore, we review the potential targets provided by the epigenome for the development of future diagnostics, preventive strategies, and therapy for cardiovascular disease. Finally, we provide some suggestions for future directions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Harst et al. (2017) studied this question.

synapsesocial.com/papers/6a1f9d28ca632e8fa1a52adahttps://doi.org/10.1016/j.jacc.2017.05.067
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis2013 · 64 citations
  2. 2Transcriptional Regulation of Endothelial Arginase 2 by Histone Deacetylase 22014 · 64 citations
  3. 3Epigenomic Co-localization and Co-evolution Reveal a Key Role for 5hmC as a Communication Hub in the Chromatin Network of ESCs2016 · 48 citations
  4. 4Maternal Genistein Alters Coat Color and Protects Avy Mouse Offspring from Obesity by Modifying the Fetal Epigenome2006 · 940 citations
  5. 5Genome-wide methylation profiles in coronary artery ectasia2017 · 11 citations